Tara Masterson
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 35
- Multiple Myeloma Research and Treatments 34
- Oncology 27
- Peptidase Inhibition and Analysis 14
- HER2/EGFR in Cancer Research 8
- CAR-T cell therapy research 6
- Cancer Treatment and Pharmacology 4
- Co-authors
- María‐Victoria Mateos (17 shared papers)Ajai Chari (18 shared papers)Philippe Moreau (13 shared papers)Niels W.C.J. van de Donk (13 shared papers)Jesús F. San Miguel (10 shared papers)Brandi Hilder (18 shared papers)Xiang Qin (13 shared papers)Christoph Heuck (22 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (7 papers)Blood Cancer Journal (2 papers)HemaSphere (2 papers)Clinical Lymphoma Myeloma & Leukemia (9 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Tara Masterson
38 papers receiving 642 citations
Tara Masterson's Hit Papers
Peers
Comparison fields: 5 of 57
- Hematology 431
- Oncology 349
- Genetics 107
- Radiology, Nuclear Medicine and Imaging 181
- Immunology 151
Countries citing papers authored by Tara Masterson
This map shows the geographic impact of Tara Masterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Masterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Masterson more than expected).
Fields of papers citing papers by Tara Masterson
This network shows the impact of papers produced by Tara Masterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Masterson. The network helps show where Tara Masterson may publish in the future.
Co-authors
The 25 scholars most cited alongside Tara Masterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 80 | |
| 2 | 2023 | 59 | |
| 3 | GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review Hit paper breakdown → | 2024 | 51 |
| 4 | 2015 | 49 | |
| 5 | 2015 | 48 | |
| 6 | 2018 | 33 | |
| 7 | 2023 | 31 | |
| 8 | 2023 | 29 | |
| 9 | 2020 | 25 | |
| 10 | 2017 | 24 | |
| 11 | 2014 | 24 | |
| 12 | 2016 | 21 | |
| 13 | 2020 | 20 | |
| 14 | 2024 | 19 | |
| 15 | 2013 | 17 | |
| 16 | 2021 | 15 | |
| 17 | 2023 | 15 | |
| 18 | 2016 | 13 | |
| 19 | 2015 | 11 | |
| 20 | 2023 | 10 |
About Tara Masterson
Tara Masterson is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 42 papers that have together received 663 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Peptidase Inhibition and Analysis (14 papers), HER2/EGFR in Cancer Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), CAR-T cell therapy research (6 papers), Cancer Treatment and Pharmacology (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (431 citations), Oncology (349 citations), Genetics (107 citations), Radiology, Nuclear Medicine and Imaging (181 citations) and Immunology (151 citations). Tara Masterson has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include María‐Victoria Mateos, Ajai Chari, Philippe Moreau, Niels W.C.J. van de Donk, Jesús F. San Miguel, Brandi Hilder, Xiang Qin, Christoph Heuck, Jaszianne Tolbert and Thomas Renaud. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Cancer Journal, HemaSphere and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.